Kangchen Pharmaceutical announced that as of July 31, 2026, the company had repurchased a total of 19.98 million shares, accounting for 1.26% of the company's total share capital. The highest purchase price was 51.40 yuan/share, the lowest price was 28.36 yuan/share, and the total amount paid was 784.3339 million yuan. The company reviewed and approved the share repurchase plan on October 15, 2025. The repurchase period is 12 months from the date of review and approval by the board of directors. The total repurchase capital is not less than 50 million yuan and no more than 100 million yuan for employee stock ownership plans or equity incentives.

Kangchen Pharmaceutical announced that as of July 31, 2026, the company had repurchased a total of 19.98 million shares, accounting for 1.26% of the company's total share capital. The highest purchase price was 51.40 yuan/share, the lowest price was 28.36 yuan/share, and the total amount paid was 784.3339 million yuan. The company reviewed and approved the share repurchase plan on October 15, 2025. The repurchase period is 12 months from the date of review and approval by the board of directors. The total repurchase capital is not less than 50 million yuan and no more than 100 million yuan for employee stock ownership plans or equity incentives.